Kewaunee Scientific (NASDAQ:KEQU) CEO Sells $43,090.00 in Stock

Kewaunee Scientific Corporation (NASDAQ:KEQU) CEO Thomas David Hull III sold 1,000 shares of the stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $43.09, for a total value of $43,090.00. Following the completion of the sale, the chief executive officer directly owned 38,719 shares in the company, valued at approximately $1,668,401.71. This represents a 2.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Thomas David Hull III also recently made the following trade(s):

• On Monday, September 29th, Thomas David Hull III sold 1,854 shares of Kewaunee Scientific stock. The stock was sold at an average price of $43.42, for a total value of $80,500.68.
• On Wednesday, September 24th, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The shares were sold at an average price of $43.62, for a total transaction of $43,620.00.
• On Tuesday, September 23rd, Thomas David Hull III sold 721 shares of Kewaunee Scientific stock. The shares were sold at an average price of $44.00, for a total transaction of $31,724.00.
• On Friday, September 19th, Thomas David Hull III sold 773 shares of Kewaunee Scientific stock. The stock was sold at an average price of $45.34, for a total transaction of $35,047.82.
• On Thursday, September 18th, Thomas David Hull III sold 652 shares of Kewaunee Scientific stock. The shares were sold at an average price of $46.00, for a total transaction of $29,992.00.

Kewaunee Scientific Price Performance

Shares of KEQU opened at $42.86 on Friday. The company has a market capitalization of $123.01 million, a P/E ratio of 10.38 and a beta of 0.68. Kewaunee Scientific Corporation has a twelve month low of $30.33 and a twelve month high of $71.33. The company has a quick ratio of 1.63, a current ratio of 2.32 and a debt-to-equity ratio of 0.88. The firm has a 50 day moving average of $51.64 and a 200 day moving average of $45.21.

Kewaunee Scientific (NASDAQ:KEQU) last issued its earnings results on Wednesday, September 10th. The technology company reported $1.10 EPS for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.The business had revenue of $71.10 million for the quarter.

Hedge Funds Weigh In On Kewaunee Scientific

Institutional investors and hedge funds have recently bought and sold shares of the stock. First Trust Advisors LP increased its position in Kewaunee Scientific by 3.4% in the second quarter. First Trust Advisors LP now owns 6,726 shares of the technology company’s stock worth $395,000 after buying an additional 222 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Kewaunee Scientific by 0.9% during the 2nd quarter. Geode Capital Management LLC now owns 24,013 shares of the technology company’s stock valued at $1,410,000 after acquiring an additional 223 shares during the period. IFP Advisors Inc increased its holdings in Kewaunee Scientific by 61.5% in the 1st quarter. IFP Advisors Inc now owns 945 shares of the technology company’s stock worth $37,000 after acquiring an additional 360 shares in the last quarter. Bank of America Corp DE raised its stake in Kewaunee Scientific by 2,605.9% during the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after acquiring an additional 443 shares during the period. Finally, Raymond James Financial Inc. bought a new stake in Kewaunee Scientific during the 2nd quarter worth approximately $60,000. 32.69% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

KEQU has been the subject of a number of recent analyst reports. Weiss Ratings reissued a “hold (c+)” rating on shares of Kewaunee Scientific in a research report on Saturday, September 27th. Wall Street Zen upgraded shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock has a consensus rating of “Hold”.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.